{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:04:37Z","timestamp":1757703877328},"reference-count":20,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2004,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The diagnosis of autoimmune bullous diseases is based on clinical observation and on the presence of autoantibodies directed to molecules involved in the adhesion systems of the skin. Immunofluorescence assays are the currently accepted method for detection of autoantibodies; such assays depend greatly on the skill of operators and are difficult to standardize. Recombinant desmoglein-1 (Dsg1), Dsg3, and BP180 peptides, the main autoantigens in pemphigus or bullous pemphigoid, have been used to develop new quantitative enzyme immunoassays (EIA) for the detection of specific antibodies. The present study was undertaken to evaluate the sensitivity and specificity of these immunoassays and to determine the correlation between the results and the clinical aspects of diseases. Serum samples from patients with pemphigus vulgaris, pemphigus foliaceus, bullous pemphigoid, or mucous membrane pemphigoid, from healthy individuals, and from patients with unrelated autoimmune conditions were tested. Anti-desmoglein reactivity was detected in all the patients with pemphigus and in none of the controls. Patients with the more benign form of cutaneous disease had anti-Dsg1 antibodies, while patients with deeper cutaneous lesions or with mucosal involvement had anti-Dsg3 reactivity also, or exclusively. The BP180-based assay was positive for 66.6% of patients with bullous pemphigoid and for none of the patients with mucous membrane pemphigoid, and no reactivity was detected in the control sera. In conclusion, the anti-Dsg1 and anti-Dsg3 assays are useful in the diagnosis of pemphigus and provide information on the clinical phenotype of the disease. However, the sensitivity of EIA for detection of autoantibodies in bullous pemphigoid should be improved by the use of additional antigens or epitopes.<\/jats:p>","DOI":"10.1128\/cdli.11.4.762-765.2004","type":"journal-article","created":{"date-parts":[[2004,7,8]],"date-time":"2004-07-08T18:30:51Z","timestamp":1089311451000},"page":"762-765","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of Recombinant Antigen-Based Assays for Diagnosis of Bullous Autoimmune Diseases"],"prefix":"10.1128","volume":"11","author":[{"given":"G.","family":"D'Agosto","sequence":"first","affiliation":[{"name":"Laboratory of Clinical Pathology"},{"name":"Clinical Dermatology Division, Istituto San Gallicano IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Latini","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pathology"},{"name":"Clinical Dermatology Division, Istituto San Gallicano IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Carducci","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pathology"},{"name":"Clinical Dermatology Division, Istituto San Gallicano IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mastroianni","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pathology"},{"name":"Clinical Dermatology Division, Istituto San Gallicano IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vento","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pathology"},{"name":"Clinical Dermatology Division, Istituto San Gallicano IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Cordiali","family":"Fei","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pathology"},{"name":"Clinical Dermatology Division, Istituto San Gallicano IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0092-8674(91)90360-B","volume":"67","year":"1991","unstructured":"Amagai, M., V. Klaus-Kovtun, and J. R. Stanley. 1991. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell67:869-877.","journal-title":"Cell"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/1523-1747.ep12606168","volume":"104","year":"1995","unstructured":"Amagai, M., T. Hashimoto, K. J. Green, N. Shimizu, and T. Nishikawa. 1995. Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. J. Investig. Dermatol.104:895-901.","journal-title":"J. Investig. Dermatol."},{"key":"e_1_3_2_4_2","first-page":"220","volume":"13","year":"1999","unstructured":"Ameglio, F., L. D'Auria, P. Cordiali-Fei, E. Trento, G. D'Agosto, A. Mastroianni, A. Giannetti, and B. Giacalone. 1999. Anti-intercellular substance antibody log titres are correlated with serum concentrations of interleukin-6, interleukin-15 and tumour necrosis factor-alpha in patients with pemphigus vulgaris: relationship with peripheral blood neutrophil counts, disease severity and duration and patients' age. J. Biol. Regul. Homeost. Agents13:220-224.","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0923-1811(00)00149-3","volume":"26","year":"2001","unstructured":"Amo, Y., T. Ohkawa, M. Tatsuta, Y. Hamada, T. Fujimura, K. Katsuoka, and T. Hashimoto. 2001. Clinical significance of enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. J. Dermatol. Sci.26:14-18.","journal-title":"J. Dermatol. Sci."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1517\/13543784.9.9.2017","volume":"9","year":"2000","unstructured":"Braun, N., and T. Bosch. 2000. Immunoadsorption, current status and future developments. Expert Opin. Investig. Drugs9:2017-2038.","journal-title":"Expert Opin. Investig. Drugs"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0738-081X(00)00196-6","volume":"19","year":"2001","unstructured":"Chan, L. S. 2001. Mucous membrane pemphigoid. Clin. Dermatol.19:703-711.","journal-title":"Clin. Dermatol."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2133.1997.tb03701.x","volume":"137","year":"1997","unstructured":"D'Auria, L., P. Cordiali Fei, M. Pietravalle, C. Ferraro, A. Mastroianni, C. Bonifati, B. Giacalone, and F. Ameglio. 1997. The serum levels of sE-selectin are increased in patients with bullous pemphigoid or pemphigus vulgaris. Correlation with the number of skin lesions and recovery after corticosteroid therapy. Br. J. Dermatol.137:59-64.","journal-title":"Br. J. Dermatol."},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1046\/j.1365-2230.2000.00624.x","volume":"25","year":"2000","unstructured":"Harman, K. E., M. J. Gratian, P. T. Seed, B. S. Bhogal, S. J. Challacombe, and M. M. Black. 2000. Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3. Clin. Exp. Dermatol.25:236-240.","journal-title":"Clin. Exp. Dermatol."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1007\/s00403-002-0366-3","volume":"295","year":"2003","unstructured":"Hashimoto, T. 2003. Recent advances in the study of the pathophysiology of pemphigus. Arch. Dermatol. Res.295:S2-S11.","journal-title":"Arch. Dermatol. Res."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.4049\/jimmunol.159.4.2010","volume":"159","year":"1997","unstructured":"Ishii, K., M. Amagai, R. P. Hall, T. Hashimoto, A. Takayanagi, S. Gamou, N. Shimizu, and T. Nishikawa. 1997. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J. Immunol.159:2010-2017.","journal-title":"J. Immunol."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1346-8138.2003.tb00395.x","volume":"30","year":"2003","unstructured":"Lee, J. B., T. Fumimori, K. Kurose, O. Mori, and T. Hashimoto. 2003. A case of bullous pemphigoid successfully treated by plasmapheresis: assessment of the change in titers of circulating antibodies by immunoblotting and enzyme-linked immunosorbent assay. J. Dermatol.30:326-331.","journal-title":"J. Dermatol."},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1172\/JCI116856","volume":"92","year":"1993","unstructured":"Liu, Z., L. A. Diaz, J. L. Troy, A. F. Taylor, D. J. Emery, J. A. Fairley, and G. J. Giudice. 1993. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J. Clin. Investig.92:2480-2488.","journal-title":"J. Clin. Investig."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1172\/JCI5252","volume":"103","year":"1999","unstructured":"Mahoney, M. G., Z. Wang, K. Rothenberger, P. J. Koch, M. Amagai, and J. R. Stanley. 1999. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J. Clin. Investig.103:461-468.","journal-title":"J. Clin. Investig."},{"key":"e_1_3_2_15_2","first-page":"544","volume":"19","year":"2001","unstructured":"Matusim, D. F., and B. B. Adams. 2001. Immunofluorescence in dermatology. J. Am. Acad. Dermatol.19:544-550.","journal-title":"J. Am. Acad. Dermatol."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0738-081X(00)00170-X","volume":"19","year":"2001","unstructured":"Powell, A. M., and M. Black. 2001. A stepwise approach to the diagnosis of blisters in the clinic. Clin. Dermatol.19:598-606.","journal-title":"Clin. Dermatol."},{"key":"e_1_3_2_17_2","first-page":"174","volume":"136","year":"2000","unstructured":"Schmidt, E., K. Obe, E. B. Br\u00f6cker, and D. Zillikens. 2000. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch. Dermatol.136:174-178.","journal-title":"Arch. Dermatol."},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1172\/JCI114036","volume":"83","year":"1989","unstructured":"Stanley, J. R. 1989. Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases. J. Clin. Investig.83:1443-1448.","journal-title":"J. Clin. Investig."},{"key":"e_1_3_2_19_2","first-page":"654","year":"1999","unstructured":"Stanley, J. R. 1999. Bullous pemphigoid, p. 654-667. In I. M. Freedberg et al. (ed.), Fitzpatrick's dermatology in general medicine. McGraw-Hill, New York, N.Y.","journal-title":"Fitzpatrick's dermatology in general medicine"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s004030050392","volume":"291","year":"1999","unstructured":"Zillikens, D., and G. J. Giudice. 1999. BP180\/type XVII collagen: its role in acquired and inherited disorders of the dermal-epidermal junctions. Arch. Dermatol. Res.291:187-194.","journal-title":"Arch. Dermatol. Res."},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0923-1811(99)00019-5","volume":"20","year":"1999","unstructured":"Zillikens, D. 1999. Acquired skin disease of hemidesmosomes. J. Dermatol. Sci.20:134-154.","journal-title":"J. Dermatol. Sci."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.11.4.762-765.2004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.11.4.762-765.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T23:37:44Z","timestamp":1682725064000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CDLI.11.4.762-765.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["10.1128\/CDLI.11.4.762-765.2004"],"URL":"https:\/\/doi.org\/10.1128\/cdli.11.4.762-765.2004","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7]]},"assertion":[{"value":"2004-02-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-04-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}